-
Date: August 24, 2011Roundtable ID: CV8613Citation: Med Roundtable Cardiovasc Ed. ; 2(4): 256 - 262.
Cardiac Resynchronization Therapy
Moderator:
There is no moderator for this particular article.
Discussants:
There are no discussants for this particular article.
-
Summary:
Dr. Jonathan Steinberg from Columbia University moderated the topic "Cardiac Resynchronization Therapy" with Drs. Andrew Epstein from the University of Pennsylvania and Angelo Auricchio from the Foundation Cardiocentro participating.
- The discussion focused primarily on:
- (1) the benefits, risks, and limitations of cardiac resynchronization therapy (CRT);
- (2) the challenges of CRT compared with implantable cardioverter-defibrillator/pacemaker therapy;
- (3) identification of the best candidates for CRT; and
- (4) the incorporation of medical and device management.
- (Med Roundtable Cardiovasc Ed. 2011;2(4):256-262) ©2011 FoxP2 Media, LLC
-
Compounds:No compounds discussed.Trials:
ACT, AMICA, CARE-HF, COMPANION, MADIT-CRT, PABA CHF, RAFT, REPLACE, REVERSE
Please subscribe to use our print features or to download PDF files.